香山股份(002870.SZ)所屬行業已變更為汽車製造業(代碼C36)
格隆匯6月17日丨香山股份(002870.SZ)公佈,公司原所屬行業類別為儀器儀表製造業(代碼C40)。2020年12月,公司通過支付現金方式收購寧波均勝羣英汽車系統股份有限公司51%股權後,主營業務增加了汽車零部件相關業務。根據《上市公司行業分類指引》中“當上市公司某類業務的營業收入比重大於或等於50%,則將其劃入該業務相對應的行業”的規定,經中國上市公司協會行業分類專家委員會確定、中國證券監督管理委員會核准發佈(具體詳見中國證券監督管理委員會網站披露的《2021年1季度上市公司行業分類結果》),公司所屬行業已變更為:汽車製造業(代碼C36)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.